ALNY vs DUK · P/E 76, rev $1.29B vs P/E 19, rev $31.74B
Alnylam Pharmaceuticals Inc (ALNY) versus Duke Energy Corporation (DUK) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Not investment advice. Open the ALNY and DUK stock pages for the full models.
Not investment advice.